Quvium Overview
- Year Founded
-
2009

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Quvium General Information
Description
Developer of a medical device designed to assist people with chronic and acute respiratory conditions. The company's wearable cough monitor predicts and prevents attacks or flare-ups, reducing emergency room visits, hospitalizations and even deaths, enabling asthma as well as cystic fibrosis patients and people with chronic obstructive pulmonary disease to get access to treatment and enhanced medical care.
Contact Information
Website
www.quvium.co.ukCorporate Office
- Discovery Park
- Ramsgate Road
- Sandwich CT13 9ND
- England, United Kingdom
Corporate Office
- Discovery Park
- Ramsgate Road
- Sandwich CT13 9ND
- England, United Kingdom
Quvium Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
6. Later Stage VC (Series A) | 01-Jul-2020 | Cancelled | Generating Revenue | |||
5. Later Stage VC | 05-Apr-2019 | Completed | Generating Revenue | |||
4. Later Stage VC | 11-Dec-2017 | Completed | Generating Revenue | |||
3. Grant | 03-Nov-2017 | Completed | Generating Revenue | |||
2. Later Stage VC | 23-Nov-2016 | $1.68M | $2.08M | Completed | Generating Revenue | |
1. Equity Crowdfunding | 22-Jun-2015 | $400K | $400K | Completed | Generating Revenue |
Quvium Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 79,700 | $0.000001 | $4.12 | $4.12 | 1x | $4.12 | 5.01% | |
Ordinary | 81,600 | $0.000001 | $4.85 | $4.85 | 1x | $4.85 | 5.13% |
Quvium Patents
Quvium Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-201505214-D0 | Cough detection, analysis, and communication platform | Inactive | 26-Mar-2015 | ||
GB-2536699-A | Cough detection, analysis, and communication platform | Inactive | 26-Mar-2015 | ||
US-20210038116-A1 | Cough detection, analysis, and communication platform | Inactive | 22-Jul-2013 | ||
US-10820832-B2 | Cough detection, analysis, and communication platform | Inactive | 22-Jul-2013 | ||
GB-201601781-D0 | Cough detection, annalysis,and communication platform | Inactive | 22-Jul-2013 | A61B5/0823 |
Quvium Signals
Quvium Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Angel (individual) | Minority | |||
GrowthInvest | Venture Capital | Minority | ||
NCL Technology Ventures | Venture Capital | Minority | ||
Angel (individual) | Minority | |||
Creative UK | Venture Capital | Minority |
Quvium FAQs
-
When was Quvium founded?
Quvium was founded in 2009.
-
Where is Quvium headquartered?
Quvium is headquartered in Sandwich, United Kingdom.
-
What is the size of Quvium?
Quvium has 10 total employees.
-
What industry is Quvium in?
Quvium’s primary industry is Monitoring Equipment.
-
Is Quvium a private or public company?
Quvium is a Private company.
-
What is Quvium’s current revenue?
The current revenue for Quvium is
. -
How much funding has Quvium raised over time?
Quvium has raised $3.6M.
-
Who are Quvium’s investors?
GrowthInvest, NCL Technology Ventures, , and Creative UK are 5 of 7 investors who have invested in Quvium.
,
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »